Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Scrambler therapy for chronic pancreatitis pain

Official title: A Pilot Study of Scrambler Therapy for Painful Chronic Pancreatitis

Run by Johns Hopkins University · NCT07174609 · Data updated 2026-11-12

We will test whether Scrambler Therapy can reduce persistent abdominal pain in adults with chronic pancreatitis who haven't found relief from standard treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedDecember 1, 2026
Study endsDecember 1, 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT07174609 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with chronic pancreatitis who continue to have significant abdominal pain despite medical, endoscopic, or surgical treatment, can consent in English, and can attend in-person sessions and phone follow-up.

Probably not a fit

People with implanted electrical devices, active skin conditions preventing electrode placement, recent major cardiac or neurologic events, pregnancy, or those unable to complete in-person visits or follow-up are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-arm pilot will enroll about 40 adults with chronic pancreatitis and refractory abdominal pain. Participants undergo 5–10 daily Scrambler Therapy sessions of 30–40 minutes with electrodes placed near (but not on) painful areas and intensity adjusted to a comfortable tingling sensation. Pain ratings (0–10 VAS) are collected before and after each session, and participants are followed for 3 months with weekly pain ratings and standardized questionnaires including PROMIS and Patient Global Impression of Change. Secondary outcomes include opioid use, proportions achieving 30% and 50% pain reduction, and monitoring for adverse events such as mild skin irritation.

Why it matters

Potential benefit: If successful, Scrambler Therapy could offer a non-invasive way to lessen abdominal pain and reduce opioid reliance for people with chronic pancreatitis.

How similar studies have gone: Scrambler Therapy has shown benefit in small studies for neuropathic and cancer-related pain, but its use specifically for pancreatic pain is largely untested and remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years and older
* Diagnosis of chronic pancreatitis with refractory abdominal pain
* Able to provide written informed consent in English
* Sufficient English language ability to complete study questionnaires
* Reliable and regular access to a phone for follow-up

Exclusion Criteria:

* Unable or unwilling to provide written consent
* History or presence of a significant medical or psychiatric condition that would interfere with study participation
* Pregnant or lactating women
* Coronary stents or implanted metallic/electrical devices (pacemaker, defibrillator, aneurysm clips)
* History of epilepsy, traumatic brain injury, or myocardial infarction within the past 6 months
* Skin conditions preventing electrode placement (e.g., open wounds)
* Any condition that, in the investigator's opinion, places the participant at increased risk or prevents full compliance with study procedures

Where it's running

  • Johns Hopkins Green Spring Station
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Mahya Faghih — Johns Hopkins University
  • Study coordinator: Mahya Faghih
  • Email: mfaghih2@jh.edu
  • Phone: 443-287-4680

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.